Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Miami, Miami, Florida; and.
Miami Veterans Affairs Medical Center, Miami, Florida.
Ann Am Thorac Soc. 2023 Nov;20(11):1587-1594. doi: 10.1513/AnnalsATS.202209-837OC.
Landmark studies of long-term oxygen therapy (LTOT) in patients with chronic obstructive pulmonary disease (COPD) used arterial oxygen pressure (Pa) to define severe hypoxemia; however, oxygen saturation as measured by pulse oximetry (Sp) is commonly used instead. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines recommend evaluation with arterial blood gas (ABG) analysis if Sp is ⩽92%. This recommendation has not been evaluated in stable outpatients with COPD undergoing testing for LTOT. To evaluate the performance of Sp compared with ABG analysis of Pa and arterial oxygen saturation (Sa) to detect severe resting hypoxemia in patients with COPD. Retrospective analysis of paired Sp and ABG values from stable outpatients with COPD who underwent LTOT assessment in a single center. We calculated false negatives (FNs) as an Sp >88% or >89% in the presence of pulmonary hypertension with a Pa ⩽55 mm Hg or ⩽59 mm Hg in the presence of pulmonary hypertension. Test performance was assessed using receiver operating characteristic (ROC) analysis, intraclass correlation coefficient (ICC), test bias, precision, and accuracy root-mean-square (A). An adjusted multivariate analysis was used to evaluate factors affecting Sp bias. Of 518 patients, the prevalence of severe resting hypoxemia was 74 (14.3%), with 52 missed by Sp (FN, 10%), including 13 (2.5%) with an Sp > 92% (occult hypoxemia). FNs and occult hypoxemia in Black patients were 9% and 1.5%, respectively, and were 13% and 5%, respectively, among active smokers. The correlation between Sp and Sa was acceptable (ICC = 0.78; 95% confidence interval, 0.74-0.81); and the bias of Sp was 0.45%, with a precision of 2.6 (-4.65 to +5.55%) and A of 2.59. These measurements were similar in Black patients, but in active smokers, correlation was lower and bias showed greater overestimation of Sp. ROC analysis suggests that the optimal Sp cutoff to warrant LTOT evaluation by ABG analysis is ⩽94%. Sp as the only measure of oxygenation carries a high FN rate in detecting severe resting hypoxemia in patients with COPD undergoing evaluation for LTOT. Reflex measurement of Pa by ABG analysis should be used as recommended by GOLD, ideally at a cutoff higher than an Sp ⩽92%, especially in active smokers.
对慢性阻塞性肺疾病(COPD)患者进行长期氧疗(LTOT)的里程碑式研究使用动脉血氧分压(Pa)来定义严重低氧血症;然而,脉搏血氧饱和度(Sp)的测量值通常被用于替代。全球慢性阻塞性肺疾病倡议(GOLD)指南建议,如果 Sp ⩽92%,则通过动脉血气(ABG)分析进行评估。这项建议尚未在接受 LTOT 评估的稳定门诊 COPD 患者中进行评估。 评估 Sp 与 ABG 分析 Pa 和动脉血氧饱和度(Sa)的性能,以检测 COPD 患者的严重静息性低氧血症。 对在单一中心接受 LTOT 评估的稳定门诊 COPD 患者的 Sp 和 ABG 值进行回顾性分析。我们计算了假阴性(FN),即在存在肺动脉高压时 Sp ⩾88%或 ⩾89%,而在存在肺动脉高压时 Pa ⩽55mmHg 或 ⩽59mmHg。使用接收者操作特征(ROC)分析、组内相关系数(ICC)、测试偏倚、精度和准确性均方根(A)评估测试性能。使用调整后的多变量分析评估影响 Sp 偏倚的因素。 在 518 例患者中,严重静息性低氧血症的患病率为 74 例(14.3%),其中 52 例 Sp 漏诊(FN,10%),包括 13 例(2.5%) Sp ⩾92%(隐匿性低氧血症)。黑人和吸烟者中的 FN 和隐匿性低氧血症分别为 9%和 1.5%,13%和 5%。Sp 和 Sa 之间的相关性可以接受(ICC ⁇ 0.78;95%置信区间,0.74-0.81);Sp 的偏倚为 0.45%,精度为 2.6(-4.65 至 +5.55%),A 为 2.59。这些测量在黑人患者中相似,但在吸烟者中,相关性较低,Sp 的估计偏差更大。ROC 分析表明,为通过 ABG 分析进行 LTOT 评估而确定的最佳 Sp 截止值为 ⩽94%。 在接受 LTOT 评估的 COPD 患者中,仅用 Sp 测量氧合状态会导致严重静息性低氧血症的 FN 率很高。建议按照 GOLD 的建议,使用 ABG 分析进行 Pa 的反射性测量,理想情况下截止值高于 Sp ⩽92%,尤其是在吸烟者中。